A detailed history of Jackson Square Partners, LLC transactions in Sight Sciences, Inc. stock. As of the latest transaction made, Jackson Square Partners, LLC holds 1,609,922 shares of SGHT stock, worth $10.7 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
1,609,922
Previous 1,629,746 1.22%
Holding current value
$10.7 Million
Previous $8.41 Million 1.08%
% of portfolio
0.36%
Previous 0.28%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$4.02 - $5.89 $79,692 - $116,763
-19,824 Reduced 1.22%
1,609,922 $8.5 Million
Q4 2023

Feb 08, 2024

BUY
$1.29 - $5.86 $225,410 - $1.02 Million
174,737 Added 12.01%
1,629,746 $8.41 Million
Q3 2023

Nov 13, 2023

SELL
$2.88 - $8.8 $752,241 - $2.3 Million
-261,195 Reduced 15.22%
1,455,009 $4.9 Million
Q2 2023

Aug 11, 2023

BUY
$7.46 - $10.67 $3.26 Million - $4.66 Million
437,143 Added 34.18%
1,716,204 $14.2 Million
Q1 2023

May 11, 2023

BUY
$8.44 - $13.35 $585,373 - $925,915
69,357 Added 5.73%
1,279,061 $11.2 Million
Q4 2022

Feb 09, 2023

BUY
$5.58 - $13.94 $2.04 Million - $5.1 Million
366,093 Added 43.4%
1,209,704 $14.8 Million
Q3 2022

Nov 14, 2022

BUY
$6.1 - $11.41 $1.52 Million - $2.84 Million
248,560 Added 41.77%
843,611 $5.36 Million
Q2 2022

Aug 12, 2022

BUY
$6.61 - $11.99 $864,389 - $1.57 Million
130,770 Added 28.17%
595,051 $5.35 Million
Q1 2022

May 13, 2022

SELL
$11.56 - $17.9 $1.52 Million - $2.35 Million
-131,443 Reduced 22.06%
464,281 $5.37 Million
Q4 2021

Feb 14, 2022

BUY
$17.36 - $27.36 $4.43 Million - $6.99 Million
255,405 Added 75.05%
595,724 $10.5 Million
Q3 2021

Nov 12, 2021

BUY
$22.34 - $39.1 $7.6 Million - $13.3 Million
340,319 New
340,319 $7.73 Million

Others Institutions Holding SGHT

About Sight Sciences, Inc.


  • Ticker SGHT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,826,200
  • Market Cap $319M
  • Description
  • Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...
More about SGHT
Track This Portfolio

Track Jackson Square Partners, LLC Portfolio

Follow Jackson Square Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jackson Square Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jackson Square Partners, LLC with notifications on news.